ConcertAI enhances CancerLinQ Suite for oncology trials

ConcertAI has announced enhancements to its CancerLinQ Suite, incorporating AI-driven trial matching and contextualised patient insights. The CancerLinQ Suite uses AI to convert unstructured data into actionable insights and unifies quality governance. The TriaLinQ module within the CancerLinQ Suite offers enhanced patient eligibility matching. Credit: PeopleImages / Shutterstock.com. ConcertAI has announced enhancements to its CancerLinQ Suite, incorporating AI-driven trial matching and contextualised patient insights. These updates aim to support oncologists and care teams in processing structured and unstructured data, delivering timely intelligence for trial enrolment and treatment decisions within existing workflows. LOA and PTSR Model Gene Therapy to Target…

Source: Clinical Trials Arena